RVTY vs ILMN vs A Stock Comparison

Revvity, Illumina and Agilent Technologies Prices as of Nov 3, 2026 Peers: Industry group
1 more company in this comparison (BRKR) Create a free account to keep reading and compare up to 10 companies.
RVTY Revvity, Inc.
$163.63 +8.0% 1M +76.0% 1Y
Market cap
$17.93B
P/E
75.5x
Revenue (TTM)
$2.91B
Div. yield
0.00%
Life Sciences Tools Healthcare
ILMN Illumina, Inc.
$238.21 -12.8% 1M +98.5% 1Y
Market cap
$34.18B
P/E
38.2x
Revenue (TTM)
$4.54B
Div. yield
–
Life Sciences Tools Healthcare
5 wins
A Agilent Technologies, Inc.
$175.40 +4.6% 1M +21.2% 1Y
Market cap
$49.88B
P/E
34.6x
Revenue (TTM)
$7.37B
Div. yield
0.01%
Life Sciences Tools Healthcare
7 wins

Head to Head

12 decided of 12

Agilent Technologies leads on 7 of the 12 questions below (Agilent Technologies 7, Illumina 5). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionRVTYILMNALeader
Larger companyMarket capitalisation $17.93B $34.18B $49.88B A
Cheaper on earningsLower P/E, profitable companies only 75.5x 38.2x 34.6x A
Cheaper on forward earningsLower price / next fiscal year consensus EPS 32.1x 47.7x 26.8x A
Faster revenue growthRevenue growth, trailing twelve months +4.1% +5.8% +8.6% A
More profitableNet margin, trailing twelve months 8.2% 19.7% 19.5% ILMN
Better return on capitalReturn on invested capital 3.1% 16.6% 13.1% ILMN
Less leveragedLower net debt / EBITDA 2.8x 0.4x 1.1x ILMN
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.01% A
Better 1-year returnPrice return, last 12 months +76.0% +98.5% +21.2% ILMN
Better 5-year returnAnnualised price return, 5 years -1.0%/yr -10.3%/yr +2.2%/yr A
Less volatileAnnualised volatility, 1 year 40.7% 50.0% 32.6% A
Higher overall scoreMean of the five percentile scores vs peers 57/100 75/100 61/100 ILMN

Percentile Scorecard

RVTYILMNA

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisRVTYILMNA
Valuation 68 #73 of 229 58 #98 of 229 57 #100 of 229
Growth 28 #160 of 221 75 #56 of 221 36 #143 of 221
Profitability 80 #43 of 209 99 #4 of 209 92 #18 of 209
Financial Health 48 #126 of 240 61 #94 of 240 56 #106 of 240
Shareholder Returns 63 #55 of 147 81 #29 of 147 67 #49 of 147
Overall 57 75 61
  • RVTY ranked among 248 companies in Medical Devices and Diagnostics
  • ILMN ranked among 248 companies in Medical Devices and Diagnostics
  • A ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodRVTYILMNASPY
1 month +8.0%-12.8%+4.6% -2.0%
3 months +47.1%+17.3%+26.0% -2.2%
6 months +77.3%+71.3%+49.2% +4.2%
Year to date +69.1%+81.6%+28.9% +10.6%
1 year +76.0%+98.5%+21.2% +10.4%
3 years +85.6%+109.4%+60.9% +73.6%
3 years, per year +22.9%+28.0%+17.2% +20.2%
5 years -4.9%-41.9%+11.3% +61.6%
5 years, per year -1.0%-10.3%+2.2% +10.1%
10 years +226.2%+82.2%+301.7% +261.3%
10 years, per year +12.6%+6.2%+14.9% +13.7%

Risk

MeasureRVTYILMNASPY
Volatility, 1Y 40.7%50.0%32.6% 12.8%
Downside volatility, 1Y 36.6%49.1%27.9% 12.8%
Beta vs S&P 500, 1Y 1.261.070.92 1.00
Return / volatility, 1Y 1.871.970.65 0.81
Max drawdown, 5Y -59.2%-82.9%-39.6% -25.4%
From 52-week high -1.3%-18.9%-3.4% -3.2%
52-week high $165.78$293.69$181.54 $779.14
52-week low $82.26$114.44$110.24 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleRVTYILMNA
P/E now vs peer median 76.9xmedian 28.1x 40.2xmedian 28.1x 34.3xmedian 28.1x
P/S now vs peer median 6.3xmedian 2.9x 7.9xmedian 2.9x 6.7xmedian 2.9x
EV/EBITDA now vs peer median 26.3xmedian 18.0x 29.5xmedian 18.0x 27.0xmedian 18.0x
P/FCF now vs peer median 32.1xmedian 24.8x 34.1xmedian 24.8x 39.0xmedian 24.8x
P/B now vs peer median 2.5xmedian 2.3x 11.5xmedian 2.3x 6.7xmedian 2.3x
PEG now vs peer median -2.47median 0.95 0.97median 0.95 3.49median 0.95

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsRVTYILMNA
Revenue $2.91B $4.54B $7.37B
Gross profit $1.60B $3.08B $3.97B
Operating income $358.85M $960.00M $1.64B
Net income $237.55M $895.00M $1.44B
Free cash flow $568.85M $1.06B $1.27B
R&D $215.83M $975.00M $485.00M
EPS (diluted) $2.13 $5.85 $5.09
Cash & equivalents $1.02B $1.29B $1.76B
Total debt $3.21B $1.79B $3.95B
Shares (diluted) 111.63M 153.00M 283.00M
Enterprise value $14.20B $28.89B $42.76B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricRVTYILMNA
P/E 76.9x 40.2x 34.3x
P/FCF 32.1x 34.1x 39.0x
P/Operating cash flow 28.6x 29.3x 30.7x
P/S 6.3x 7.9x 6.7x
P/B 2.5x 11.5x 6.7x
P/Tangible book 3.6x 13.1x 7.7x
EV/EBITDA 26.3x 29.5x 27.0x
EV/EBIT 57.0x 38.0x 31.5x
EV/Revenue 7.0x 8.0x 7.0x
EV/FCF 35.9x 34.5x 40.8x
EV/Operating cash flow 32.0x 29.6x 32.1x
PEG (3Y EPS CAGR) -2.47 0.97 3.49

Growth

14 metrics
MetricRVTYILMNA
Revenue growth (1Y) 4.1% 5.8% 8.6%
Revenue CAGR (3Y) 0.9% -0.7% 1.8%
Gross profit growth (1Y) 2.3% 8.5% 11.2%
Gross profit CAGR (3Y) -0.4% 4.4% 3.7%
Operating income growth (1Y) -5.5% 23.1% 13.5%
Operating income CAGR (3Y) -3.7% 30.0% 5.1%
Net income growth (1Y) -16.7% 27.5% 18.0%
Net income CAGR (3Y) -33.8% 40.9% 8.3%
EPS growth (1Y) -12.3% 28.3% 18.9%
EPS CAGR (3Y) -31.2% 41.3% 9.8%
Operating cash flow growth (1Y) 6.2% 9.6% 7.6%
Operating cash flow CAGR (3Y) 86.9% 47.5% -1.9%
Free cash flow growth (1Y) 9.5% 5.7% 16.5%
Free cash flow CAGR (3Y) 64.8% 126.5% -3.7%

Profitability

14 metrics
MetricRVTYILMNA
Gross margin 55.0% 67.9% 53.8%
EBITDA margin 26.6% 27.3% 25.9%
Operating margin 12.3% 21.2% 22.2%
Pretax margin 9.0% 23.3% 22.5%
Net margin 8.2% 19.7% 19.5%
FCF margin 19.5% 23.3% 17.2%
Operating cash flow margin 21.9% 27.1% 21.8%
Return on equity 3.3% 29.9% 19.9%
Return on assets 2.0% 13.3% 10.7%
Return on invested capital 3.1% 16.6% 13.1%
Return on capital employed 3.3% 17.2% 14.6%
Asset turnover 0.2x 0.7x 0.5x
Cash conversion (OCF / net income) 2.7x 1.4x 1.1x
Stock comp / revenue 0.8% 5.9% 1.8%

Financial Health

11 metrics
MetricRVTYILMNA
Debt / assets 26.6% 26.3% 28.3%
Debt / equity 0.4x 0.6x 0.5x
Net debt / EBITDA 2.8x 0.4x 1.1x
Debt / FCF 5.6x 1.7x 3.1x
Liabilities / assets 40.0% 53.8% 47.3%
Equity / assets 60.0% 46.2% 52.7%
Interest coverage 3.7x 9.8x 15.5x
Current ratio 1.8x 2.6x 2.1x
Quick ratio 1.4x 1.8x 1.4x
Cash ratio 0.8x 1.2x 0.8x
Altman Z-score 3.43 7.39 5.81

Shareholder Returns

7 metrics
MetricRVTYILMNA
Dividend yield 0.2% – 0.6%
Net buyback yield 2.6% 1.0% 0.6%
Shareholder yield 2.7% 1.0% 1.2%
Payout ratio (earnings) 13.4% – 19.9%
Payout ratio (FCF) 5.6% – 22.6%
Dividend growth (1Y) -6.3% – 2.1%
Dividend CAGR (3Y) -6.1% – 3.1%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusRVTYILMNA
Forward P/E 32.1xFY2026 47.7xFY2026 26.8xFY2026
EPS, next fiscal year $5.10FY2026 $4.99FY2026 $6.54FY2026
EPS growth, next FY +0.8%FY2026 +3.1%FY2026 +17.0%FY2026
EPS growth, the year after +11.0% +25.7% +0.3%
Revenue, next fiscal year $2.98BFY2026 $4.52BFY2026 $7.87BFY2026
Revenue growth, next FY +4.0%FY2026 +4.1%FY2026 +15.3%FY2026
Revenue growth, the year after -2.0% +12.0% -5.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersRVTYILMNA
Held by institutions 100.0% 100.0% 92.6%
Institutions holding 547 935 1,126
Change in shares held, QoQ -1.3% +0.0% +3.2%
Institutions buying 303 464 602
Institutions selling 161 331 351
Buyers to sellers 1.88 1.40 1.72

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

RVTYILMNA
RVTY 1.00 0.56 0.65
ILMN 0.56 1.00 0.51
A 0.65 0.51 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, RVTY, ILMN and A?

Agilent Technologies (A) is the largest by market capitalisation: Revvity (RVTY) $17.93B, Illumina (ILMN) $34.18B, Agilent Technologies (A) $49.88B.

Which stock is cheaper, RVTY, ILMN and A?

Agilent Technologies (A) trades on the lowest price-to-earnings ratio (Revvity (RVTY) 75.5x, Illumina (ILMN) 38.2x, Agilent Technologies (A) 34.6x). On next year's consensus earnings, Agilent Technologies (A) is cheapest (Revvity (RVTY) 32.1x, Illumina (ILMN) 47.7x, Agilent Technologies (A) 26.8x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Agilent Technologies (A) grew revenue fastest over the trailing twelve months: Revvity (RVTY) +4.1%, Illumina (ILMN) +5.8%, Agilent Technologies (A) +8.6%.

Which company is more profitable?

Illumina (ILMN) has the highest net margin (Revvity (RVTY) 8.2%, Illumina (ILMN) 19.7%, Agilent Technologies (A) 19.5%). On return on invested capital, Illumina (ILMN) leads (Revvity (RVTY) 3.1%, Illumina (ILMN) 16.6%, Agilent Technologies (A) 13.1%).

Which stock has performed better?

Over the past year Illumina (ILMN) returned the most: Revvity (RVTY) +76.0%, Illumina (ILMN) +98.5%, Agilent Technologies (A) +21.2%. Over five years, Agilent Technologies (A) compounded fastest (Revvity (RVTY) -1.0%/yr, Illumina (ILMN) -10.3%/yr, Agilent Technologies (A) +2.2%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Agilent Technologies (A) has the highest dividend yield: Revvity (RVTY) 0.00%, Illumina (ILMN) 0.00%, Agilent Technologies (A) 0.01%. Illumina (ILMN) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Agilent Technologies (A) has been the steadiest (Revvity (RVTY) 40.7%, Illumina (ILMN) 50.0%, Agilent Technologies (A) 32.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, RVTY, ILMN and A?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Agilent Technologies (A) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.